Trial Profile
A Single Center, Placebo-controlled Trial to Evaluate the Effects of Elobixibat in Colonic Motor Functions in Patients With Chronic Idiopathic Constipation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Elobixibat (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 02 Jun 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrial.gov.
- 24 Mar 2015 New trial record